(Q38582664)

4 September 2017

0 references

Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis (English)

1 reference

functional colonic disease

4 September 2017

0 references

0 references

1 reference

1 reference

1 reference

3

1 reference

4 September 2017

2

Michael Camilleri

1 reference

4 September 2017

Nelson Valentin

1

1 reference

4 September 2017

Priya Vijayvargiya

4

1 reference

4 September 2017

Andres Acosta

5

1 reference

4 September 2017

Alfred D Nelson

6

1 reference

4 September 2017

M Hassan Murad

7

1 reference

4 September 2017

language of work or name

English

0 references

publication date

7 September 2015

1 reference

4 September 2017

1 reference

4 September 2017

65

1 reference

4 September 2017

12

1 reference

4 September 2017

1951-1959

1 reference

SeHCAT retention values as measured with a collimated and an uncollimated gamma camera: a method comparison study

4 September 2017

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Methods for diagnosis of bile acid malabsorption in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Bile acid malabsorption in patients with chronic diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Use of the SeHCAT test in the investigation of diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Colonoscopy and SeHCAT for investigation of chronic diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Prognosis of adult-onset idiopathic bile acid malabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Radiological bile acid absorption test 75SeHCAT in patients with diarrhoea of unknown cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Undiagnosed coeliac disease at age seven: population based prospective birth cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Seroprevalence, correlates, and characteristics of undetected coeliac disease in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

The prevalence of celiac disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309889

10.1136/GUTJNL-2015-309889

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference